GL1X · GenesisL1 explorer

MolNFT v1 · #113269 · protein

Structure of L1198F mutant human anaplastic lymphoma kinase in complex with pf-06463922 ((10R)-7-amino-12-fluoro-2,10,16-trimethyl- 15-oxo- 10,15,16,17-tetrahydro-2H-8,4-(METHENO)PYRAZOLO(4,3-H)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile).

5AA9 · ALK tyrosine kinase receptor: “Structure of L1198F mutant human anaplastic lymphoma kinase in complex with pf-06463922…”. X-ray diffraction, 1 ligand (5P8), 1 pocket (best druggability 0.62). MolNFT v1 #113269 on GenesisL1: 3D…

PDB
5AA9
Type
protein
Length
295 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
5P8
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein29543% helix, 15% strandQ9UM73

Ligands and binding sites

  • 5P8 · (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13730.620.78445P8

Compared structures

  • 5AA9 · Structure of L1198F Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.